Dyne Therapeutics, Inc.
HealthcareNASDAQ:DYN · NASDAQ Global Select
+$0.24 today
Vol 0.92M · Avg 1.79M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+26.23%
Period High
$24.29
Period Low
$8.18
Latest
$18.19
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.15B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.47B
CG Oncology, Inc. Common stock
NASDAQ:CGON
$5.25B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$4.99B
Celcuity Inc.
NASDAQ:CELC
$4.32B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.11B
Telix Pharmaceuticals Limited
NASDAQ:TLX
$3.24B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.40B
Ascentage Pharma Group International
NASDAQ:AAPG
$409.04M
What is the latest DYN filing?
The latest filing shown is 4 dated Jun 9, 2026.
How many recent filings does DYN have?
Intrinsic Alpha currently shows 20 recent filings for DYN.
Explore More
Continue the stock analysis
Jump to another research area for this company.